Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your thyroid nodule has been confirmed as non-cancerous (benign) by two separate needle biopsy tests
- Your thyroid nodule does not show any worrying signs of cancer on an ultrasound scan
- You are experiencing cosmetic concerns, symptoms, rapid nodule growth, or worry about possible cancer changes
- You are unable to have surgery or have chosen not to have surgery
- You are able to be followed up and monitored for at least 6 months
Who may not be able to join:
- Your biopsy results showed a type of growth called a follicular neoplasm, or any sign of cancer
- Your biopsy was non-cancerous, but your ultrasound showed concerning features such as very dark appearance, unclear edges, a shape that is taller than it is wide, or tiny calcium deposits
- You have a thyroid nodule that is mainly filled with fluid (cystic nodule)
- You have paralysis of the vocal cord on the opposite side of the neck from the nodule
- You have had radiation treatment to your head or neck in the past
- You are not able to commit to at least 6 months of follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8613811237313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
volume reduction rate; rate of nodule regrowth
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.